Mode
Text Size
Log in / Sign up
N/A N=55

CTAG Dissection/Trauma Post Marketing Surveillance Japan

Thoracic Aortic Aneurysm · Thoracic Aorta Injury · Thoracic Aortic Dissection

Enrolled (actual)
55
Serious AEs
32.7%
Results posted
Oct 2024
Primary outcome: Primary: Primary Entry Tear Exclusion — 21; 26; 27; 22 Participants

Study Design & Population

Study type
Observational
Phase
N/A
Interventions
Conformable GORE® TAG® Thoracic Endoprosthesis (Device)
Age
Pediatric, Adult, Older Adult
Sex
All
Sponsor
W.L.Gore & Associates
Primary completion
Dec 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Primary Entry Tear Exclusion
21; 26; 27; 22; 19; 17
PRIMARY
Aortic Rupture
2
PRIMARY
Major Device-related Adverse Events
3; 0
PRIMARY
Secondary Intervention Treatment
5; 0
PRIMARY
Change in Minimum True Lumen Diameter Adjacent to Treated Segment
1; 6; 18; 1; 3; 26
PRIMARY
Change in Minimum True Lumen Diameter Distal to Treated Segment
0; 13; 11; 1; 11; 14
PRIMARY
Change in Maximum False Lumen Diameter Adjacent to Treated Segment
18; 5; 1; 23; 4; 0
PRIMARY
Change in Maximum False Lumen Diameter Distal to Treated Segment
14; 10; 0; 19; 5; 1
PRIMARY
Change in Maximum Lesion Diameter
1; 2; 0; 1; 2; 0

Summary

Post Marketing Surveillance of the Conformable GORE® TAG® Thoracic Endoprosthesis

Eligibility Criteria

Inclusion Criteria for Acute, Complicated Stanford Type B Aortic Dissection:

  • Patient present with acute complicated type B aortic dissection
  • Patient who do not respond to medical therapy
  • Time from symptom onset to dissection diagnosis ≤ 14 days
  • Adequate iliac / femoral access or conduit
  • Aortic inner diameter at proximal extent of proximal landing zone in the range of 16-42 mm
  • ≥ 20 mm landing zone proximal to the primary entry tear; proximal extent of the landing zone must not be dissected

Inclusion Criteria for Traumatic Aortic Transection:

  • Patient has traumatic aortic transection that requires repair as determined by treating physician
  • Adequate iliac / femoral access
  • Aortic inner diameter in the range of 16-42 mm on the proximal and distal sides
  • ≥ 20 mm non-aneurysmal aorta neck proximal and distal to the lesion
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05414318). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search